Pfizer launches ‘catfish’ counterfeit medicines campaign
The campaign is aimed at students who don't know what they could be buying online.
15th October 2019
Latest news
FDA ‘yes’ for Eli Lilly’s Reyvow
The approval marks the first new class of acute migraine treatment approved by the FDA in more than two decades.
15th October 2019
Survey reveals 'workforce crisis' in NHS
Performance statistics throughout the last year have shown “strain on an already stretched system."
15th October 2019
Tailor-made drug shows success in Batten disease
The process could pave the way for more rapid delivery of individualised treatments.
15th October 2019
Rituxan hits targets in late-stage pemphigus vulgaris trial
The study is still ongoing, with patients participating in a 48-week safety follow-up period.
14th October 2019
Novo, Bluebird Bio ink in vivo genome research agreement
The three-year collaboration will utilise Bluebird Bio’s proprietary mRNA-based megaTAL technology.
14th October 2019
NHS to improve young people’s hospital mental health, learning disability and autism services
The services are all part of the NHS Long Term plan.
14th October 2019
New mental health outreach funding for homeless
New teams will identify rough sleepers in need of help, support them to access a GP and then on to the new expert psychiatric help.
14th October 2019
Clovis’ Rubraca approved for Cancer Drugs Fund
NICE initially rejected the drug for use on the NHS, citing uncertainties in evidence and questioning the pricing.
14th October 2019
MGB Biopharma reveals positive mid-stage diarrhoea data
To date, MGB-BP-3 is the only antibiotic that has the killing power, combined with the speed of action, to eradicate the disease within the first few hours of exposure.
11th October 2019
Sanofi opens new HQ
The "state of the art" facility will be the new base for 500 of the 1,200 employees in the UK.
11th October 2019
GSK recalls prescription Zantac
The FDA claims to have found “unacceptable” levels of carcinogen in the medicine.
11th October 2019
Cuts in alcohol duty linked to 2000 deaths
The knock-on effects of these cuts has also seen an increase of over 61,000 hospital admissions since 2012 at an estimated cost of £317m to the NHS.
11th October 2019
1/3 of people with sight loss suffer mental health problems
84% of Brits fear losing their sight more than any other sense.
11th October 2019
Bayer, Sensyne to form new AI ‘LifeHub’
Earlier this week Sensyne announced a formal research agreement with the MHRA.
10th October 2019
